Araujo Andre B, Chiu Gretchen R, Christian Jennifer B, Kim Hae Young, Evans William J, Clark Richard V
Department of Epidemiology, New England Research Institutes Inc., Watertown, MA, USA.
Clin Endocrinol (Oxf). 2014 May;80(5):662-70. doi: 10.1111/cen.12212. Epub 2013 Apr 19.
While low high-density lipoprotein cholesterol (HDL-C) is associated with increased risk of cardiovascular (CV) events, there are limited data evaluating the association of longitudinal change in HDL-C with CV event risk in older populations. The aim of this study was to examine the association between within-subject changes in HDL-C levels and CV events in an older population.
Observational cohort study.
1293 men and 1422 women age ≥50 years, with ≥2 consecutive HDL measurements, and no prior CVD as part of Framingham Offspring Study.
A clinical CV event was defined as the first occurrence of any of the following: coronary heart disease (coronary death, myocardial infarction, coronary insufficiency and angina), cerebrovascular event, peripheral artery disease or heart failure.
Median total follow-up time across subjects was 9·6 years. Change in HDL-C was evaluated as between-exam (approximately 3·5 years) percentage change in HDL-C, categorized as ≥10% decrease, <10% change (stable) and ≥10% increase. Crude and adjusted sex-specific Cox hazards regression models with change in HDL-C as a time-dependent covariate quantified the association with CV events. Mean baseline age of the analysis sample was 53 years. There were 233 and 111 CV events among men and women, respectively. Change in HDL-C was not significantly associated with CVD incidence in men or women, without or with adjustment for confounders including baseline HDL-C or use of relevant medications.
In conclusion, relatively short-term (3·5 years) changes in HDL-C levels do not affect CV events in men and women.
虽然低高密度脂蛋白胆固醇(HDL-C)与心血管(CV)事件风险增加相关,但评估老年人群中HDL-C的纵向变化与CV事件风险之间关联的数据有限。本研究的目的是检验老年人群中HDL-C水平的个体内变化与CV事件之间的关联。
观察性队列研究。
1293名男性和1422名年龄≥50岁的女性,连续进行了≥2次HDL测量,且作为弗雷明汉心脏研究后代队列的一部分,无既往心血管疾病史。
临床CV事件定义为首次出现以下任何一种情况:冠心病(冠心病死亡、心肌梗死、冠状动脉供血不足和心绞痛)、脑血管事件、外周动脉疾病或心力衰竭。
受试者的中位总随访时间为9.6年。HDL-C的变化评估为两次检查之间(约3.5年)HDL-C的百分比变化,分为降低≥10%、变化<10%(稳定)和升高≥10%。以HDL-C变化作为时间依赖性协变量的粗性别特异性和校正后Cox风险回归模型量化了与CV事件的关联。分析样本的平均基线年龄为53岁。男性和女性分别有233例和111例CV事件。无论是否校正包括基线HDL-C或使用相关药物在内的混杂因素,HDL-C的变化与男性或女性的心血管疾病发病率均无显著关联。
总之,HDL-C水平相对短期(3.5年)的变化不会影响男性和女性的CV事件。